Literature DB >> 12811586

Oncostatin M, a multifunctional cytokine.

M Tanaka1, A Miyajima.   

Abstract

Oncostatin M (OSM) is a multifunctional cytokine that belongs to the Interleukin (IL)-6 subfamily. Among the family members, OSM is most closely related to leukemia inhibitory factor (LIF) and it in fact utilizes the LIF receptor in addition to its specific receptor in the human. While OSM was originally recognized by its unique activity to inhibit the proliferation of tumor cells, accumulating evidence now indicates that OSM exhibits many unique biological activities in inflammation, hematopoiesis, and development. Here, we review the profile of OSM activities, receptors, and signal transduction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811586     DOI: 10.1007/s10254-003-0013-1

Source DB:  PubMed          Journal:  Rev Physiol Biochem Pharmacol        ISSN: 0303-4240            Impact factor:   5.545


  81 in total

1.  Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events.

Authors:  Jennifer M Green; Karen Leu; Angela Worth; Richard B Mortensen; David K Martinez; Peter J Schatz; Don M Wojchowski; Peter R Young
Journal:  Exp Hematol       Date:  2012-03-06       Impact factor: 3.084

2.  Mitogen-activated protein kinase signaling controls basal and oncostatin M-mediated JUNB gene expression.

Authors:  Mellissa J Hicks; Qiuping Hu; Erin Macrae; James DeWille
Journal:  Mol Cell Biochem       Date:  2015-02-08       Impact factor: 3.396

3.  Formation of large vacuoles induced by cooperative effects of oncostatin M and dexamethasone in human fetal liver cells.

Authors:  Tamihide Matsunaga; Mie Toba; Tsuyoshi Teramoto; Mitsue Mizuya; Kaori Aikawa; Shigeru Ohmori
Journal:  Med Mol Morphol       Date:  2008-05-11       Impact factor: 2.309

4.  Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis.

Authors:  Gregor Hoermann; Sabine Cerny-Reiterer; Andrea Perné; Miriam Klauser; Konrad Hoetzenecker; Katharina Klein; Leonhard Müllauer; Marion Gröger; Sebastian M B Nijman; Walter Klepetko; Peter Valent; Matthias Mayerhofer
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

5.  Endothelium-derived GM-CSF influences expression of oncostatin M.

Authors:  Wafa M Elbjeirami; Elizabeth M Donnachie; Alan R Burns; C Wayne Smith
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-20       Impact factor: 4.249

6.  JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.

Authors:  Kazuhiko Shien; Vassiliki A Papadimitrakopoulou; Dennis Ruder; Carmen Behrens; Li Shen; Neda Kalhor; Juhee Song; J Jack Lee; Jing Wang; Ximing Tang; Roy S Herbst; Shinichi Toyooka; Luc Girard; John D Minna; Jonathan M Kurie; Ignacio I Wistuba; Julie G Izzo
Journal:  Mol Cancer Ther       Date:  2017-07-20       Impact factor: 6.261

7.  Lack of kinin B₁ receptor potentiates leptin action in the liver.

Authors:  Raphael Gomes Fonseca; Vicencia Micheline Sales; Eduardo Ropelle; Carlos Castilho Barros; Lila Oyama; Silvia Saiuli Iuki Ihara; Mário Jose Abdalla Saad; Ronaldo Carvalho Araújo; João Bosco Pesquero
Journal:  J Mol Med (Berl)       Date:  2013-02-06       Impact factor: 4.599

Review 8.  Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage.

Authors:  Olaf Dammann; Wolfgang Bueter; Alan Leviton; Pierre Gressens; Christiane E L Dammann
Journal:  Neonatology       Date:  2007-11-09       Impact factor: 4.035

9.  Prostaglandin E₂ induces oncostatin M expression in human chronic wound macrophages through Axl receptor tyrosine kinase pathway.

Authors:  Kasturi Ganesh; Amitava Das; Ryan Dickerson; Savita Khanna; Narasimham L Parinandi; Gayle M Gordillo; Chandan K Sen; Sashwati Roy
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

10.  Oncostatin M-stimulated apical plasma membrane biogenesis requires p27(Kip1)-regulated cell cycle dynamics.

Authors:  Sven C D Van IJzendoorn; Delphine Théard; Johanna M Van Der Wouden; Willy Visser; Kacper A Wojtal; Dick Hoekstra
Journal:  Mol Biol Cell       Date:  2004-07-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.